Position history for VIKING GLOBAL INVESTORS LP's holdings in NEWAMSTERDAM PHARMA COMPANY
VIKING GLOBAL INVESTORS LP holds 4.2M shares of NAMS (NEWAMSTERDAM PHARMA COMPANY), worth $134.6M as of 2026-Q1. NAMS represents 0.4% of VIKING GLOBAL INVESTORS LP's portfolio.
Current Value
$134.6M
Current Shares
4.2M
Total Value Change
-$19.6M
Total Shares Change
-3.8M
Other major holders of NAMS: Capital World Investors, RA CAPITAL MANAGEMENT, L.P.
Unchanged |
| 4.2M |
0.0% |
| $134.6M |
| 0.4% |
| $30.41 |
0 |
| 2025-Q4 | Decreased | 4.2M | -35.1% | $147.5M | 0.4% | $34.74 | 0 |
| 2025-Q3 | Decreased | 6.5M | -7.2% | $184.2M | 0.5% | $27.52 | 0 |
| 2025-Q2 | Unchanged | 7M | 0.0% | $126.4M | 0.4% | $18.57 | 0 |
| 2025-Q1 | Unchanged | 7M | 0.0% | $142.9M | 0.5% | $21.76 | 0 |
| 2024-Q4 | Decreased | 7M | -13.0% | $179.3M | 0.6% | $25.60 | 0 |
| 2024-Q3 | Unchanged | 8M | 0.0% | $133.2M | 0.5% | $16.23 | 0 |
| 2024-Q2 | Unchanged | 8M | 0.0% | $154.2M | 0.6% | $19.21 | 0 |